本页面由Tiger Trade Technology Pte. Ltd.提供服务

Syndax Pharmaceuticals, Inc.

13.95
-2.6000-15.71%
盘后:14.070.1245+0.89%18:12 EDT
成交量:680.69万
成交额:9,417.12万
市值:12.46亿
市盈率:-5.56
高:14.74
开:14.61
低:13.49
收:16.55
52周最高:25.59
52周最低:12.99
股本:8,929.71万
流通股本:8,029.50万
量比:4.07
换手率:8.48%
股息:- -
股息率:- -
每股收益(TTM):-2.5100
每股收益(LYR):-3.2949
净资产收益率:-255.93%
总资产收益率:-18.67%
市净率:82.50
市盈率(LYR):-4.23

数据加载中...

2024/03/18

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/12

重要事件披露

Form 8-K - Current report
2023/11/29

SEC问询函

Form CORRESP - Correspondence
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/11/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/02

重要事件披露

Form 8-K - Current report
2023/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/03

重要事件披露

Form 8-K - Current report